Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 
applications

Labuhn, Maurice; Adams, Felix F.; Ng, Michelle; Knoess, Sabine; Schambach, Axel; Charpentier, Emmanuelle M.; Schwarzer, Adrian; Mateo, Juan L.; Klusmann, Jan-Henning; Heckl, Dirk

doi:10.1093/nar/gkx1268

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

このアイテムの新しいバージョンが利用可能です:
https://pure.mpg.de/pubman/item/item_2581314_2

詳細要約

公開

学術論文

Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications

MPS-Authors

/persons/resource/persons194799

Charpentier, Emmanuelle M.
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

Nucl_Acids_Res_2018_46_1375.pdf
(出版社版), 2MB

付随資料 (公開)

There is no public supplementary material available

引用

Labuhn, M., Adams, F. F., Ng, M., Knoess, S., Schambach, A., Charpentier, E. M., Schwarzer, A., Mateo, J. L., Klusmann, J.-H., & Heckl, D. (2018). Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications. Nucleic Acids Research (London), 46(3), 1375-1385. doi:10.1093/nar/gkx1268.

引用: https://hdl.handle.net/21.11116/0000-0001-2F5E-3

要旨

要旨はありません